KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Pension (2016 - 2026)

Gsk has reported Pension over the past 18 years, most recently at -$2.3 billion for Q1 2026.

  • For Q1 2026, Pension rose 2.98% year-over-year to -$2.3 billion; the TTM value through Mar 2026 reached -$2.3 billion, up 2.98%, while the annual FY2025 figure was -$2.2 billion, 193.79% down from the prior year.
  • Pension for Q1 2026 was -$2.3 billion at Gsk, down from -$2.2 billion in the prior quarter.
  • Over five years, Pension peaked at $3.0 billion in Q4 2022 and troughed at -$3.5 billion in Q3 2022.
  • A 5-year average of -$1.6 billion and a median of -$2.4 billion in 2025 define the central range for Pension.
  • Biggest five-year swings in Pension: surged 92.82% in 2022 and later plummeted 777.55% in 2023.
  • Year by year, Pension stood at $3.0 billion in 2022, then dropped by 3.99% to $2.9 billion in 2023, then fell by 17.62% to $2.4 billion in 2024, then tumbled by 193.79% to -$2.2 billion in 2025, then decreased by 1.83% to -$2.3 billion in 2026.
  • Business Quant data shows Pension for GSK at -$2.3 billion in Q1 2026, -$2.2 billion in Q4 2025, and -$2.2 billion in Q3 2025.